x
ServiziMenu principaleHome
You are here: Home > Educational Opportunities > Future Events > Masterclass in Clinical Oncology - Summer edition
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Masterclass in Clinical Oncology - Summer edition

10.05.2024  -  25.06.2024

HYBRID EVENT

MASTERCLASS

Description

Chairs: F. A. Peccatori, IT – H. Azim Jr, EG
Host Chairs: P. Casali, IT – B. Vincenzi, IT

Aims, objectives and teaching format

The ESO Masterclass is a full immersion, clinical oriented event designed for medical and clinical oncologists with 3-4 years experience in oncology who would like to receive further training on the treatment of tumours from a multidisciplinary point of view. The programme exposes participants to a full spectrum of issues in clinical oncology and to practice-oriented training.
The Masterclass is organized into:

  • Plenary lectures on state-of-the-art clinical treatments with reference to clinical guidelines given by renowned international faculty.
  • Interactive workshops on how to write and publish a paper, communication, how to deal with data uncertainty and managing burnout.
  • Clinical case presentations/tumour board simulation where each participant presents and discusses a case with an international faculty of top experts in each tumour type.

The Masterclass is divided into two educational parts:

  1. Pre-recorded online lectures
  2. In-person event

The online lectures are released before the in-person event to give each participant the opportunity to prepare themselves in their own time and at their own pace.

The in-person event is held in the style of a 3-and-half-day ‘retreat’, giving participants the opportunity to begin building an international oncology network as well as the chance to interact with renowned faculty in an informal environment over a number of days.

The Masterclass is held entirely in English and fluency in English is necessary for admission.

The ESO Masterclass in Clinical Oncology: Summer edition is a closed event for selected participants only.

Information

LANGUAGE

The Masterclass will be held in English and translation will not be provided.

FEE

The Masterclass will take place at University Campus Biomedico, Rome, Italy.

A fee of:

  • 300 EUR for participant working in High-Middle Income Countries *
  • 200 EUR for participants working in Low-Middle income countries *

covers:

  • Access to the course and its educational resources
  • Accommodation for 4 nights 
  • Group transfer to and from the Masterclass venue, each day of the course 
  • Meals according to the programme

The fee does not cover travel costs, these should be organized and paid by the participant.

A discount of 100 EUR is given to participants who are already ESCO members.

*as defined by the World Bank

The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.


ACCREDITATION

Participants will be issued a certificate of attendance (minimum attendance: 75% of the online part + 100% of the in-person event). An online evaluation questionnaire and learning assessment test will need to be completed for both parts in order to get the certificate that will be sent by email.
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

     ESCO - The ESO College

Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enroll in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

ORGANISING SECRETARIAT

Alice Ciocchini
European School of Oncology
ph +39 335 133 28 33
e-mail: aciocchini@eso.net

Dolores Knupfer
European School of Oncology
ph +41 91 820 09 50
e-mail: dknupfer@eso.net

 

Programme

Block 1 - 10.05.2024 - On-demand material

Masterclass in Clinical Oncology - Block 1 (PRE-RECORDED LECTURES)

Block 2 - 21.06.2024 / 25.06.2024 - Rome, Italy

Masterclass in Clinical Oncology - Summer edition

Application

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY

60 PARTICIPANTS WILL BE SELECTED.

Applications deadline: 31st March 2024

IDEAL PROFILE OF THE MASTERCLASS CANDIDATE
  • Aged up to 40 years
  • 2-3 years’ experience in medical oncology
  • Involvement in scientific activities and clinical trials
  • Fluency in English
  • From ESO’s geographical reach
HOW TO APPLY

Interested oncologists should apply online (at the top of this page) providing:

  • Letter describing motivation for attending
  • Supporting letter from head of department or mentor
  • CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
  • Clinical case (please, use the provided template - Download HERE)
  • Professional experience form (please, use the provided template - Download HERE)
CLINICAL CASE PRESENTATION

During the in-person selected participants will have the chance to present a clinical case as a clinical grandround discussion to the faculty and participants. A template giving details of the clinical case you would like to present should be submitted with your application. Please provide a straightforward case found in your daily clinical practice - no uncommon or extremely rare cases. 

You should include:

  • Diagnostic considerations
  • Treatment
  • Results, follow-up
  • At least three questions proposed for discussion with the faculty

If you are selected for the Masterclass, you will be asked to prepare a PowerPoint presentation of your case (max 10 slides). If we receive too many cases from one tumour group, we may ask you to change the case topic you submitted during your application. We kindly ask you to let us know your 2nd choice topic if your first choice cannot be accommodated.

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Clinical Case template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

Faculty

Roberto Angioli, University Policlinic UniCampus Biomedico, Gynaecological Cancer Dpt., Roma, IT
Riccardo A. Audisio, Trieste, IT
Hatem A. Azim Jr., Emergence Therapeutics, Medical Dept., Marseille, FR
Giulia Baciarello, San Camillo-Forlanini Hospitals, Genitourinary Oncology Dpt., Rome, IT
Joerg Beyer, University Hospital of Bern, Oncology and Medicine Dept., Bern, CH
Paolo Bruzzi, Genova, IT
Paolo Giovanni Casali, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milan, IT
Franco Cavalli, Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH
Nicoletta Colombo, Istituto Europeo di Oncologia, Programma Ginecologia Oncologica, Milano, IT
Carmen Criscitiello, European Institute of Oncology, New Drugs and Early Drug Development for Innovative Therapies Dpt., Milan, IT
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Alessandra Curioni-Fontecedro, Freiburger Spital, HFR Kantonsspital Freiburg, Department of Oncology, Freiburg, CH
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Francesca Del Bufalo, IRCCS Peadiatric Hospital Bambino Gesù, Cellular and Genic Therapy Dpt., Roma, IT
Andre D'Hoore, UZ Gasthuisberg, Dept. of Surgery, Leuven, BE
Antonio Di Meglio, Gustave Roussy Institute, Medical Oncology Dpt., Villejuif, FR
Andreas Dietz, University Hospital Leipzig, ENT Dpt., Leipzig, DE
Alexandru Eniu, Riviera-Chablais Hospital, Medical Oncology, Rennaz, CH
Andrea Ferrari, Fondazione IRCCS Istituto Nazionale dei Tumori, Div. di Oncologia Pediatrica, Milano, IT
Marco Fiore, Fondazione IRCCS Istituto Nazionale dei Tumori, Surgery Dpt., Milan, IT
Andrea Gallina, EOC - Ente Ospedaliero Cantonale, Urology Dpt., Bellinzona, CH
Fady B. Geara, Cleveland Clinic Abu Dhabi, Dept. of Radiation Oncology, Abu Dhabi, AE
Juan Francisco Grau Bejar, Vall d´Hebron University Hospital, Gynaecological Cancer Dpt., Barcelona, ES
Alessandro Gronchi, National Cancer Institute - IRCCS Foundation, Sarcomas Surgery Unit, Milano, IT
Edy Ippolito, University Campus Bio-Medico, Breast Cancer Dpt., Roma, IT
Angela Lamarca, Fundación Jiménez Díaz University Hospital, Department of Oncology – OncoHealth Institute, Madrid, ES
Pauline Leonard, National Health Service, Oncology and Communication Dpt., London, UK
Florian Lordick, University Hospital Leipzig, University Cancer Center Leipzig (UCCL), Leipzig, DE
Umberto Malapelle, University of Naples Federico II, Dpt. of Public Health, QUARTO, IT
Caterina Marchiò, FPO Istituto di Ricovero e Cura a Carattere Scientifico, Dip. di Scienze Mediche, Candiolo, IT
Olivier Michielin, Geneve University Hospital, Medical Oncology Dpt., Geneve, CH
Jarushka Naidoo, Waterford Regional Hospital, Medical Oncology Dpt., Waterford, IE
Federico Navarria, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Radiotherapy Dpt., Aviano, IT
Andrea Necchi, IRCCS San Raffaele Hospital, Genitourinary Medical Oncology Division, Milan, IT
Christoph Oing, Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Newcastle Upon Tyne, UK
Demetris Papamichael, Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY
Anes Pasic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Giuseppe Perrone, University Campus Bio-Medico, Pathology Anatomy Dpt., Roma, IT
Filippo Pietrantonio, IRCCS Istituto Nazionale dei Tumori, Gastro-intestinal cancers Dpt., Milano, IT
Philip Poortmans, Sint Augustus Hospital, Radiotherapy Dept., Wilrijk, BE
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Amanda Psyrri, Attikon University Hospital, Medical Oncology Dept., Chaidari, GR
Sara Ramella, University Campus Bio-Medico, Radiotherapy Dpt., Roma, IT
Isabelle Ray-Coquard, Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR
Erino Angelo Rendina, Universiry of Rome, Thoracic Surgery Dpt., Roma, IT
Christian Rolfo, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Center for Thoracic Oncology, New York, US
Laura Rubbia-Brandt, Hôpitaux Universitaires Genève, Pathology Dept., Geneve, CH
Manuela Schmidinger, Medical University of Vienna, Department of Urology and Comprehensive Cancer Center, Vienna, AT
Uta Schmidt-Strassburger, Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE
Isabelle Schmitt-Opitz, University Hospital Zurich, Dept. of Thoracic Surgery, Zurich, CH
Joachim Schuz, AIRC - International Agency for Research on Cancer, Environment and Lifestyle Epidemiology Branch, Lyon, FR
Cristiana Sessa, Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH
Alina Sturdza, Comprehensive Cancer Center, Medical University of Vienna, Dept. of Radiation Oncology, Wien, AT
Ian Tannock, Toronto, CA
Annalisa Trama, Milano, IT
Eric Van Cutsem, University Hospital Leuven, Digestive Oncology Dept., Leuven, BE
Alberto Vannelli, Ospedale Valduce, General Surgery Dpt., Como, IT
Bruno Vincenzi, University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT
Marco Vitellaro, INT - National Cancer Institute, General Surgery Dpt., Milano, IT
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH
Gian Franco Zannoni, Policlinico Gemelli, Anatomo-pathology Dpt., Roma, IT